Our previous study showed that Mfn2 deficiency participates in podocyte injury in a focal segmental glomerulosclerosis (FSGS) animal model by inhibiting Pink1/Parkin-associated mitophagy. This evidence concerns the gene MFN2 and focal segmental glomerulosclerosis.